Darunavir, Ritonavir, and Etravirine Pharmacokinetics in the Cervicovaginal Fluid and Blood Plasma of HIV-Infected Women

Kristine B. Patterson(University of North Carolina at Chapel Hill), Angela D. M. Kashuba(University of North Carolina at Chapel Hill), Steven H. Jennings(University of North Carolina at Chapel Hill), Joseph Mrus(University of Cincinnati Medical Center), Ron Falcon(University of North Carolina at Chapel Hill)
Antimicrobial Agents and Chemotherapy
December 21, 2010
10.1128/aac.00889-10
Cited by 18

Related Papers

Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
|Nature|2012|1.2k
Influence of Human Immunodeficiency Virus Infection on the Course of Hepatitis C Virus Infection: A Meta‐Analysis
|Clinical Infectious Diseases|2001|969
Penetration of Tenofovir and Emtricitabine in Mucosal Tissues: Implications for Prevention of HIV-1 Transmission
|Science Translational Medicine|2011|352
A Translational Pharmacology Approach to Predicting Outcomes of Preexposure Prophylaxis Against HIV in Men and Women Using Tenofovir Disoproxil Fumarate With or Without Emtricitabine
|The Journal of Infectious Diseases|2016|303
Efficacy and Tolerability of 3 Nonnucleoside Reverse Transcriptase Inhibitor–Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1
|Annals of Internal Medicine|2014|262